- Dynavax plunges on FDA rejection of HBV vaccine $DVAX
- Corbus up on scleroderma proof of concept data, but question linger $CRBP
- RNAi product for PCSK9 passes early test $MDCO $ALNY
- Gilead's cold streak in the clinic continues $GILD $INCY
- Another big shoe drops in Valeant - Philidor saga $VRX
- As seen on the stream: best of the rest, including $ARWR $EXAS $OCUL $PBYI $PFE $QURE $TSRO $ZIOP $LABU $XBI $IBB #SITC2016 #FCP4C #AHA16
Continue on to the Biotech Tweets of the Week (November 14-18, 2016)